A collagen-hyaluronic acid composite gel and its preparation method and application

By combining primary and secondary cross-linking reactions with EDC and NHS cross-linking agents and optimizing the raw material ratio and reaction conditions, a collagen-hyaluronic acid composite gel with high elastic modulus was prepared. This solved the problems of gel instability and insufficient cell proliferation in existing technologies, and improved bioactivity and stability.

CN118652447BActive Publication Date: 2024-11-05RUNMEI TIME (BEIJING) BIOTECHNOLOGY CO LTD +1
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411132818.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-11-05
Estimated Expiration
2044-08-19

AI Technical Summary

Technical Problem

Existing cross-linked hyaluronic acid gels have limited effects in filling and hydrating, and there are risks of side effects. Uneven mixing of collagen and hyaluronic acid leads to gel instability, and collagen degrades rapidly in the human body, failing to effectively promote cell proliferation.

Method used

A primary cross-linking reaction was conducted by adding the cross-linking agent solution to the hyaluronic acid solution, followed by the addition of the collagen solution for a secondary cross-linking reaction. The reaction temperature and time were controlled within a reasonable range. EDC and NHS were used as cross-linking agents, and the ratio and concentration of raw materials were optimized. Finally, purified water was used to wash away byproducts.

Benefits of technology

The obtained collagen-hyaluronic acid composite gel has high elastic modulus and good stability. It can promote cell proliferation, improve the instability of hyaluronic acid gel and the rapid degradation of collagen, and enhance bioactivity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118652447B_ABST
    Figure CN118652447B_ABST
Patent Text Reader

Abstract

The present invention relates to the field of biomedical technology, and in particular to a collagen-hyaluronic acid composite gel and its preparation method and application. The preparation method comprises the following steps: using hydrochloric acid to prepare a collagen solution with collagen; using MES buffer to prepare a hyaluronic acid solution with hyaluronic acid; using MES buffer to prepare a crosslinker solution with a crosslinker; first adding the prepared crosslinker solution to a hyaluronic acid solution for a primary crosslinking reaction, and then adding the collagen solution for a secondary crosslinking reaction to obtain a collagen-hyaluronic acid composite gel. The collagen-hyaluronic acid composite gel of the present invention has high elastic modulus and biological activity and is structurally stable.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical technology, and in particular to a collagen-hyaluronic acid composite gel and a preparation method and application thereof. Background Art

[0002] Hyaluronic acid has been widely used in medical cosmetology, drug carriers and other fields due to its excellent biocompatibility, modifiability, and biodegradability. In particular, it has been widely recognized in the market for use in injectable plastic surgery by cross-linking. However, a single cross-linked hyaluronic acid gel can only play a role in filling and hydrating, but cannot participate in or promote the proliferation of the body's own cells. In addition, the elastic modulus of cross-linked hyaluronic acid on the market is generally 500-1000 Pa, and its contour shaping ability is far from enough. For cross-linked hyaluronic acid of the same molecular weight, high elasticity means a high degree of cross-linking, and the risk of side effects caused by cross-linking agent residues will also increase.

[0003] In order to improve the problems of single cross-linked hyaluronic acid gels, collagen and hyaluronic acid are combined to prepare gels in related studies. Collagen has the function of promoting cell proliferation and growth. It is hydrolyzed in the human body and converted into a variety of amino acids. The amino acids obtained by hydrolysis can participate in the synthesis of the body's own collagen and can also provide nutrition to the body as nutrients. However, collagen itself does not have good mechanical properties as an injectable filler, and it is rapidly degraded under the action of human proteases, and its maintenance effect is extremely short. In order to improve physical properties and enhance resistance to enzyme attacks, it is necessary to stabilize the collagen structure by cross-linking. And under physiological conditions, collagen and hyaluronic acid have opposite charges, and it is very easy to form polymers and produce precipitation, resulting in uneven mixing of collagen and hyaluronic acid, which becomes a problem in constructing collagen hyaluronic acid composite gels. Summary of the invention

[0004] The present invention provides a collagen-hyaluronic acid composite gel and a preparation method and application thereof, so as to solve the above problems existing in the prior art.

[0005] According to a first aspect of the present invention, the present invention provides a method for preparing a collagen-hyaluronic acid composite gel, comprising the following steps:

[0006] The collagen is prepared into a collagen solution by using hydrochloric acid; the hyaluronic acid is prepared into a hyaluronic acid solution by using MES buffer; the cross-linking agent is prepared into a cross-linking agent solution by using MES buffer;

[0007] First, the prepared cross-linking agent solution is added to the hyaluronic acid solution to carry out a primary cross-linking reaction, and then the collagen solution is added to carry out a secondary cross-linking reaction to obtain a collagen-hyaluronic acid composite gel.

[0008] In the above scheme, the preparation method of the present invention first adds the cross-linking agent solution to the hyaluronic acid solution for a primary cross-linking reaction, which can effectively solve the problem of hyaluronic acid gel instability, and further adds collagen solution for a secondary cross-linking reaction, which can improve the function of hyaluronic acid gel to participate in or promote the proliferation of human cells, so that the obtained composite gel has biological activity. Through the synergistic effect of the primary cross-linking reaction and the secondary cross-linking reaction, a stable collagen-hyaluronic acid composite gel with a high elastic modulus can be obtained.

[0009] Furthermore, the temperature of the primary cross-linking reaction is 30-40°C, and the time is 10-30 minutes; the temperature of the secondary cross-linking reaction is 30-40°C, and the time is 2-4 hours.

[0010] In the above scheme, by controlling the temperature and time of the primary cross-linking reaction and the secondary cross-linking reaction within a reasonable range, each reaction is made more effective and more conducive to obtaining a stable collagen-hyaluronic acid composite gel.

[0011] Further, the cross-linking agent includes 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide (NHS).

[0012] In the above scheme, EDC (1-ethyl-(3-dimethylaminopropyl) carbodiimide) is a zero-length crosslinker with wide applications in biology, medicine, chemistry, etc. It can form isopeptide bonds between carboxyl and amine-reactive groups and is not incorporated into the final product. N-hydroxysuccinimide is a chemical modification reagent that converts carboxyl groups into amine-reactive NHS esters. It is used in bioconjugation, crosslinking, labeling, and fixation methods. The presence of NHS improves the efficiency of EDC-mediated conjugation. In addition, urea is a byproduct of the crosslinking reaction and can be easily removed by washing.

[0013] Furthermore, the weight ratio of the 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide to the N-hydroxysuccinimide is (1-5):1.

[0014] Optionally, the weight ratio of the 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide to the N-hydroxysuccinimide can be 1:1, 1.5:1, 2:1, 2.5:1, 3:1, 3.5:1, 4:1, 4.5:1 or 5:1, etc., and of course it can also be other values ​​within the above range, which is not limited here.

[0015] In the above scheme, by limiting the amount of EDC and NHS to a reasonable range, it is more conducive to the cross-linking reaction, thereby obtaining a composite gel with a high elastic modulus.

[0016] Furthermore, the weight ratio of the collagen, the hyaluronic acid and the cross-linking agent is (1-4): (2-6): (5-15).

[0017] In the above scheme, by limiting the weight ratio of the collagen, the hyaluronic acid and the cross-linking agent within a reasonable range, the raw materials can exert a better synergistic effect, improve the efficiency of the cross-linking reaction, and thus obtain a collagen-hyaluronic acid composite gel with a more stable structure and a better elastic modulus.

[0018] Furthermore, the mass concentration of the cross-linking agent solution is 5-15%.

[0019] Optionally, the mass concentration of the cross-linking agent solution may be 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14% or 15%, etc., and may also be other values ​​within the above range, which is not limited here.

[0020] In the above scheme, by limiting the mass concentration of the cross-linking agent solution within a reasonable range, it is more conducive to the cross-linking reaction, thereby obtaining a composite gel with a high elastic modulus.

[0021] Furthermore, the mass concentration of the collagen solution is 1-3%; the pH of the collagen solution is 3.0-5.0.

[0022] Optionally, the mass concentration of the collagen solution may be 1%, 1.5%, 2%, 2.5% or 3%, etc., and may also be other values ​​within the above range, which is not limited here.

[0023] In the above scheme, by limiting the mass concentration of the collagen solution within a reasonable range, it is more conducive to the cross-linking reaction, thereby obtaining a composite gel with a high elastic modulus.

[0024] Furthermore, the mass concentration of the hyaluronic acid solution is 2-6%; the hyaluronic acid solution is sterilized by wet heat and then subjected to a cross-linking reaction.

[0025] Optionally, the mass concentration of the hyaluronic acid solution may be 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 5.5% or 6%, etc., and may also be other values ​​within the above range, which is not limited here.

[0026] In the above scheme, by limiting the mass concentration of the hyaluronic acid solution within a reasonable range, it is more conducive to the cross-linking reaction, thereby obtaining a composite gel with a high elastic modulus.

[0027] Furthermore, after the secondary cross-linking reaction, purified water is used for washing to obtain a collagen-hyaluronic acid composite gel.

[0028] In the above scheme, by washing with purified water after the secondary cross-linking reaction, the by-products of the cross-linking reaction can be effectively removed, thereby improving the purity of the composite gel.

[0029] According to the second aspect of the present invention, the present invention further provides a collagen-hyaluronic acid composite gel, which is prepared by the above-mentioned preparation method; the elastic modulus of the collagen-hyaluronic acid composite gel is 4000-14000Pa.

[0030] According to the third aspect of the present invention, the present invention also provides the use of the above-mentioned collagen-hyaluronic acid composite gel in the preparation of beauty products.

[0031] The preparation method of a collagen-hyaluronic acid composite gel provided by the present invention first adds a cross-linking agent solution into a hyaluronic acid solution for a primary cross-linking reaction, which can effectively solve the problem of instability of the hyaluronic acid gel, and further adds a collagen solution for a secondary cross-linking reaction, which can improve the function of the hyaluronic acid gel in participating in or promoting the proliferation of human cells, so that the obtained composite gel has biological activity, and a stable collagen-hyaluronic acid composite gel with a high elastic modulus can be obtained through the synergistic effect of the primary cross-linking reaction and the secondary cross-linking reaction. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the following briefly introduces the drawings required for use in the embodiments or the description of the prior art. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0033] Figure 1 This is a SEM image of the collagen-hyaluronic acid composite gel of Example 1 of the present invention.

[0034] Figure 2 This is the SEM image of the gel of Comparative Example 1 of the present invention.

[0035] Figure 3 This is the SEM image of the gel of Comparative Example 2 of the present invention. DETAILED DESCRIPTION

[0036] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be clearly and completely described below in conjunction with the drawings of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0037] The beneficial effects of the present invention will be described below in conjunction with specific embodiments and comparative examples.

[0038] Examples 1-13

[0039] This embodiment provides a method for preparing a collagen-hyaluronic acid composite gel, comprising the following steps:

[0040] Step 1: Collagen (collagen selected is Bedi collagen) is prepared into collagen solution with hydrochloric acid, and then the pH of the solution is adjusted to 4.0 with sodium hydroxide; hyaluronic acid (molecular weight 200W) is prepared into hyaluronic acid solution with MES buffer, and the hyaluronic acid is dissolved and sterilized with wet heat (121°C, 15min); the cross-linking agent is prepared into a cross-linking agent solution with MES buffer, and the cross-linking agent includes EDC and NHS. The mass concentrations of the collagen solution, hyaluronic acid solution and cross-linking agent solution in each embodiment, and the weight ratios of EDC and NHS are shown in Table 1 below.

[0041] Step 2: First, add 1-4g of the prepared cross-linker solution to 0.4-1.2g of hyaluronic acid solution and carry out a primary cross-linking reaction at 35°C under stirring conditions for 20 minutes, then add 0.2-0.8g of collagen solution and continue to carry out a secondary cross-linking reaction at 35°C under stirring conditions for 3h. After the reaction, wash 5 times with purified water to obtain a collagen-hyaluronic acid composite gel.

[0042] Examples 14-17

[0043] This embodiment provides a method for preparing a collagen-hyaluronic acid composite gel, which is different from Embodiment 3 in that: in step 2, the time of the primary cross-linking reaction is different, specifically 10 min, 15 min, 25 min, and 30 min, respectively.

[0044] Examples 18-21

[0045] This embodiment provides a method for preparing a collagen-hyaluronic acid composite gel, which is different from Embodiment 3 in that: in step 2, the secondary cross-linking reaction time is different, specifically 1h, 2h, 4h, and 5h, respectively.

[0046] Examples 22-23

[0047] This embodiment provides a method for preparing a collagen-hyaluronic acid composite gel, which is different from Embodiment 3 in that: in step 2, the time for the primary cross-linking reaction and the secondary cross-linking reaction are 30° C. and 40° C., respectively.

[0048] Comparative Example 1

[0049] This comparative example provides a method for preparing collagen gel, wherein the preparation method is to add 1 g of a 5% cross-linking agent solution to 0.2 g of a 1% collagen solution and perform a cross-linking reaction at 35° C. for 3 hours under stirring conditions.

[0050] Comparative Example 2

[0051] This comparative example provides a method for preparing hyaluronic acid gel, wherein the preparation method is to add 1 g of a 5% cross-linking agent solution to 0.4 g of a 2% hyaluronic acid solution and perform a cross-linking reaction at 35° C. for 3 hours under stirring conditions.

[0052] Comparative Example 3

[0053] This comparative example provides a method for preparing a collagen-hyaluronic acid composite gel, wherein the preparation method is to add 1 g of a 5% cross-linking agent solution to 0.4 g of a 2% hyaluronic acid solution and 0.2 g of a 1% collagen solution, and perform a cross-linking reaction at 35° C. for 3 hours under stirring conditions.

[0054] The gel obtained in the embodiment and the comparative example was tested for elastic modulus and cell adhesion rate (centrifugation method in Appendix B of YY / T1849-2022). The elastic modulus test was performed using a rheometer (test parameters were rotor radius: 25 mm; rotor spacing: 1 mm; sample loading: 1 mL; temperature: 25°C; shear rate: 1 Hz; shear strain: 0.01-100%) to test the rheological properties of the samples. Ten different sampling points were randomly selected from each group for testing. The inter-batch stability of the EDC / NHS cross-linking effect was evaluated by the inter-group differences. The test results are shown in Table 1 below.

[0055] Table 1

[0056]

[0057] It can be seen from the results of Example 1 and Comparative Example 3 that the collagen-hyaluronic acid composite gel obtained by the present invention is more stable, and the hyaluronic acid composite improves the adhesion effect of hyaluronic acid cells. Although the concentration of the cross-linking agent increases and the adhesion rate decreases, it is still higher than that of simple hyaluronic acid.

[0058] Depend on Figure 1-3 It can be seen from the comparison results that the composite gel of Example 1 of the present invention has a reticular texture on the surface compared with Comparative Examples 1-2, and the increased roughness is conducive to cell adhesion.

[0059] The advantage of the EDC / NHS cross-linking agent used in the present invention is that the reaction conditions are mild, and its main disadvantage is that non-specific reactions are prone to occur, which affects the structure and function of the cross-linked product. Elastic modulus can be used as one of the evaluation indicators of the cross-linking effect of the collagen-hyaluronic acid composite gel of the present invention, and the higher the degree of cross-linking, the larger the elastic modulus, and the smaller the difference between groups, indicating that the cross-linking effect is more stable. As can be seen from the results of Table 1, Example 1-23 is compared with Comparative Example 3, and the gel elastic modulus error after two cross-linking is within ± 15%, and the difference between groups is small, while the error range of single cross-linking is ± 44%, and the difference between groups is large, indicating that the cross-linking effect of the cross-linking effect using secondary cross-linking is more stable than the cross-linking effect of one cross-linking, and by secondary cross-linking, the problem of unstable cross-linking effect of EDC / NHS cross-linking agent is solved. Further, the weight ratio of the cross-linking agent, the weight ratio of collagen, hyaluronic acid and the cross-linking agent, the concentration of each raw material, and the temperature and time in the cross-linking process will affect the performance of the collagen-hyaluronic acid composite gel of the present invention, and the synergistic effect of the above-mentioned process conditions is used to make the obtained collagen-hyaluronic acid composite gel stable and have a high elastic modulus.

[0060] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for preparing a collagen-hyaluronic acid composite gel, characterized in that: The steps include: The collagen is prepared into a collagen solution by using hydrochloric acid; the hyaluronic acid is prepared into a hyaluronic acid solution by using MES buffer; the cross-linking agent is prepared into a cross-linking agent solution by using MES buffer; First, the prepared cross-linking agent solution is added to the hyaluronic acid solution for a primary cross-linking reaction, and then the collagen solution is added for a secondary cross-linking reaction to obtain a collagen-hyaluronic acid composite gel; The temperature of the first cross-linking reaction is 30-40°C, and the time is 10-30min; the temperature of the second cross-linking reaction is 30-40°C, and the time is 2-4h; The cross-linking agent includes 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and N-hydroxysuccinimide, and the weight ratio of the 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide to the N-hydroxysuccinimide is (1-5):1; The weight ratio of the collagen solution, the hyaluronic acid solution and the cross-linking agent solution is (1-4): (2-6): (5-15); The pH of the collagen solution is 3.0-5.0; The hyaluronic acid solution is sterilized by wet heat and then subjected to a cross-linking reaction.

2. The method for preparing the collagen-hyaluronic acid composite gel according to claim 1, characterized in that: The mass concentration of the cross-linking agent solution is 5-15%.

3. The method for preparing the collagen-hyaluronic acid composite gel according to claim 1, characterized in that: The mass concentration of the collagen solution is 1-3%.

4. The method for preparing the collagen-hyaluronic acid composite gel according to claim 1, characterized in that: The molecular weight of the hyaluronic acid is 80-200W; the mass concentration of the hyaluronic acid solution is 2-6%.

5. The method for preparing the collagen-hyaluronic acid composite gel according to claim 1, characterized in that: After the secondary cross-linking reaction, the collagen-hyaluronic acid composite gel was obtained by washing with purified water.

6. A collagen-hyaluronic acid composite gel, characterized in that: The collagen-hyaluronic acid composite gel is prepared by the preparation method according to any one of claims 1 to 5; the elastic modulus of the collagen-hyaluronic acid composite gel is 3500-14000Pa.

7. Use of the collagen-hyaluronic acid composite gel according to claim 6 in the preparation of cosmetic products.

Citation Information

Patent Citations

  • Low immunogenicity collagen modified high bioactivity hyaluronic acid medical film and preparation method thereof

    CN108939132A

  • Implantable hyaluronic acid / collagen compositions

    US20130116188A1

  • Hyaluronic acid-collagen matrices for tissue engineering

    US20130116190A1

  • Hyaluronic acid / collagen- based dermal filler compositions and methods for making same

    WO2014039607A1